GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shanghai MicuRx Pharmaceutical Co Ltd (SHSE:688373) » Definitions » 3-Year Revenue Growth Rate

Shanghai MicuRx Pharmaceutical Co (SHSE:688373) 3-Year Revenue Growth Rate : 136.30% (As of Dec. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Shanghai MicuRx Pharmaceutical Co 3-Year Revenue Growth Rate?

Shanghai MicuRx Pharmaceutical Co's Revenue per Share for the three months ended in Dec. 2024 was ¥0.05.

During the past 12 months, Shanghai MicuRx Pharmaceutical Co's average Revenue per Share Growth Rate was 43.50% per year. During the past 3 years, the average Revenue per Share Growth Rate was 136.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 7 years, the highest 3-Year average Revenue per Share Growth Rate of Shanghai MicuRx Pharmaceutical Co was 136.30% per year. The lowest was 136.30% per year. And the median was 136.30% per year.


Competitive Comparison of Shanghai MicuRx Pharmaceutical Co's 3-Year Revenue Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Shanghai MicuRx Pharmaceutical Co's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shanghai MicuRx Pharmaceutical Co's 3-Year Revenue Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Shanghai MicuRx Pharmaceutical Co's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Shanghai MicuRx Pharmaceutical Co's 3-Year Revenue Growth Rate falls into.



Shanghai MicuRx Pharmaceutical Co 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.


Shanghai MicuRx Pharmaceutical Co  (SHSE:688373) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.


Shanghai MicuRx Pharmaceutical Co 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Shanghai MicuRx Pharmaceutical Co's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Shanghai MicuRx Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
No. 53 Edison Road, Building 101 and 2, Floor 1-4, Building 1, Pilot Free Trade Zone, Shanghai, CHN, 201210
Shanghai MicuRx Pharmaceutical Co Ltd is engaged in the discovery, development and commercialization of innovative medicines for unmet clinical needs.
Executives
Director, core technical staff
Zhao Dong Ming senior management
Yuan Hong senior management
Wang Xing Hai Senior management, core technical personnel
Li Zhi Le Director

Shanghai MicuRx Pharmaceutical Co Headlines

No Headlines